Recent evidence suggests coronary stents don't improve chest pain more than optimal medications in patients with stable coronary artery disease. …
As a cardiovascular pharmacist, you will often hear debates on the optimal duration of dual antiplatelet therapy (DAPT) after stent placement in acut…
Recent interest in colchicine ( Lodoco ) emerges from its potential to reduce cardiovascular (CV) risk due to its anti-inflammatory properties. Origi…
As a clinical pharmacist, you're likely aware that up to 30% of statin patients experience muscle pain, cramps, or weakness, typically in the lar…
As a clinical pharmacist, managing dual antiplatelet therapy (DAPT) around surgery in patients with recent coronary stents is crucial. According to A…